T3-21  Hsp90β inhibitors prevent GLT- 1 degradation but have no beneficial efficacy on absence epilepsy

PENG Yu- chen, WANG Shan, ZHANG Yong, HUANG Long-jian, ZHOU Yu-jun, WANG Xiao-liang, PENG Ying

PDF(596 KB)
PDF(596 KB)
Chinese Journal of Pharmacology and Toxicology ›› 2018, Vol. 32 ›› Issue (9) : 724-724.

T3-21  Hsp90β inhibitors prevent GLT- 1 degradation but have no beneficial efficacy on absence epilepsy

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2018, 32(9): 724-724

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(596 KB)

Accesses

Citation

Detail

Sections
Recommended

/